Salvianolate lyophilized injection (SLI) strengthens blood-brain barrier function related to ERK1/2 and Akt signaling pathways
Salvianolate lyophilized injection (SLI) strengthens blood-brain barrier function related to ERK1/2 and Akt signaling pathways
复制标题
丹参多酚酸盐冻干注射液 (SLI) 增强与 ERK1/2 和 Akt 信号通路相关的血脑屏障功能
DOI:
10.1016/j.brainres.2019.06.014
复制
发表时间:
2019-10
期刊:
影响因子:
2.9
通讯作者:
Hu Limin
中科院分区:
文献类型:
--
作者:
Zhao Chun;Li Xueli;Li Xiaojin;Xu Yangyang;Ma Mengmeng;Wang Shaoxia;Chai Lijuan;Guo Hong;Hu Limin
The salvianolate lyophilized injection (SLI) has been widely used for the treatment of acute cerebral infarction; however, the molecular mechanism of how it strengthens blood brain barrier (BBB) function is not well understood. Here, we investigated the effects of SLI on BBB function in bEnd.3 cells as well as in rats. In oxygen glucose deprivation/reoxygenation (OGD/R)-damaged bEnd.3 cells, SLI increased transepithelial electrical resistance and decreased sodium fluorescein flux. SLI-treated cells showed increased expression of tight junction proteins, including Zonula occludens-1 (ZO-1), Claudin-5 and Occludin. Furthermore, SLI led to the decrease of phosphorylation of ERK1/2, p38, and Akt. Using selective inhibitors, we found that the positive effects of SLI on barrier function were abolished in cells in which ERK1/2 and Ak signaling were inhibited. Moreover, in MCAO model rats, SLI effectively alleviated brain leakage of Evans blue, increased brain tissue ZO-1 expression and inhibited phosphorylation of ERK1/2 and Akt. Overall, these data suggest that SLI strengthens BBB function was interrelated ERK1/2 and Akt signaling pathways in cerebral vascular diseases.
登录
查看更多内容
影响因子:
4.2
作者:
Springler A;Hessenberger S;Schatzmayr G;Mayer E
通讯作者:
Mayer E
影响因子:
--
作者:
Song J;Kang SM;Lee WT;Park KA;Lee KM;Lee JE
通讯作者:
Lee JE
影响因子:
3.2
作者:
Mnh
通讯作者:
Mnh
影响因子:
7.2
作者:
Daneman, Richard;Prat, Alexandre
通讯作者:
Prat, Alexandre
影响因子:
5.5
作者:
Abdullahi, Wazir;Tripathi, Dinesh;Ronaldson, Patrick T.
通讯作者:
Ronaldson, Patrick T.